Effects of Regional Anesthesia Following Mastectomy

Sponsor
Koc University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05276440
Collaborator
(none)
182
60

Study Details

Study Description

Brief Summary

Patients of breast surgery dated between April 2016 and March 2021 will be scanned in three groups; solely induced general anesthesia, general anesthesia induced with Erector Spinae Plane Block, and general anesthesia induced with Rhomboid Block.

The investigators aimed to retrospectively compare the effectiveness of regional anesthesia techniques used in the clinic for postoperative recovery and opioid consumption in patients who underwent breast surgery.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    182 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Effects of Regional Anesthesia on Postoperative Recovery and Opioid Consumption Following Mastectomy: A Retrospective Study
    Actual Study Start Date :
    Apr 1, 2016
    Actual Primary Completion Date :
    Mar 31, 2021
    Actual Study Completion Date :
    Mar 31, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    General Anesthesia

    Erector Spinae Plane Block

    Rhomboid Block

    Outcome Measures

    Primary Outcome Measures

    1. Total opioid consumption retrieved from the patient records [up to 24 hours]

    2. Length of hospital stay [up to 1 week]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Patients underwent breast surgery under general anesthesia with or without one of the blocks; Erector Spinae Plane Block and Rhomboid Block.
    Exclusion Criteria:
    • Incomplete patient forms.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Koc University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Seçil Çetin, Principal Investigator, Koc University Hospital
    ClinicalTrials.gov Identifier:
    NCT05276440
    Other Study ID Numbers:
    • KocUniversity
    First Posted:
    Mar 11, 2022
    Last Update Posted:
    Mar 11, 2022
    Last Verified:
    Mar 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 11, 2022